Oaktree Acquisition Corp. III Life Sciences OACC

Oaktree Acquisition Corp. III Life Sciences extends business combo deadline

Item 3.02 Unregistered share sale, Item 5.03 Amends charter or bylaws, Item 5.07 Shareholder vote results

Form
8-K
Filed
Importance
Notable
  1. Extended Termination Date to Nov 25, 2026
  2. Allowing monthly extensions up to May 25, 2027
  3. 76.3% voting power present at meeting

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when Oaktree Acquisition Corp. III Life Sciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 6770 and related industry codes: the same peer list as the financial tables.